Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
676
Nova
NVMI
$13.6B
| $11.1M | 0.03% |
+1,227,600
| New | +$11.3M |
|
677
Eldorado Gold
EGO
$8.48B
| $11.1M | 0.03% |
+359,000
| New | +$13.2M |
|
|
VSI
678
DELISTED
Vitamin Shoppe Inc.
VSI
| $11.1M | 0.03% |
+247,500
| New | +$11.6M |
|
679
Littelfuse
LFUS
$10.2B
| $11.1M | 0.03% |
+148,592
| New | +$10.5M |
|
680
Forrester Research
FORR
$185M
| $11.1M | 0.03% |
+301,918
| New | +$10.8M |
|
|
SQI
681
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $11.1M | 0.03% |
+442,100
| New | +$10.3M |
|
|
AMTG
682
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $11.1M | 0.03% |
+671,800
| New | +$13.6M |
|
683
Forward Air
FWRD
$466M
| $11M | 0.03% |
+287,271
| New | +$10.9M |
|
|
MCRL
684
DELISTED
MICREL INC
MCRL
| $11M | 0.03% |
+1,111,179
| New | +$11.1M |
|
|
ANDV
685
DELISTED
Andeavor
ANDV
| $11M | 0.03% |
+209,500
| New | +$11.7M |
|
686
Mattel
MAT
$4.3B
| $10.9M | 0.03% |
+241,200
| New | +$10.8M |
|
687
National Healthcare
NHC
$3.53B
| $10.9M | 0.03% |
+228,500
| New | +$10.7M |
|
|
SSRI
688
DELISTED
Silver Standard Resources
SSRI
| $10.9M | 0.03% |
+1,721,383
| New | +$12.7M |
|
689
Canadian Pacific Kansas City
CP
$81.1B
| $10.9M | 0.03% |
+449,500
| New | +$11.3M |
|
|
KFN
690
DELISTED
KKR FINANCIAL HOLDINGS LLC COM
KFN
| $10.9M | 0.03% |
+1,029,855
| New | +$11M |
|
|
BIRT
691
DELISTED
Actuate Corp
BIRT
| $10.8M | 0.03% |
+1,629,000
| New | +$10.3M |
|
|
STEC
692
DELISTED
STEC INC COM STK
STEC
| $10.8M | 0.03% |
+1,606,310
| New | +$6.23M |
|
|
GWR
693
DELISTED
Genesee & Wyoming Inc.
GWR
| $10.8M | 0.03% |
+127,150
| New | +$11.1M |
|
|
SWY
694
DELISTED
SAFEWAY INC
SWY
| $10.8M | 0.03% |
+509,017
| New | +$11.1M |
|
|
CAMP
695
DELISTED
CalAmp Corp.
CAMP
| $10.8M | 0.03% |
+32,096
| New | +$8.78M |
|
|
MPT
696
Medical Properties Trust
MPT
$2.86B
| $10.8M | 0.03% |
+752,300
| New | +$11.9M |
|
|
CBK
697
DELISTED
Christopher & Banks Corporation
CBK
| $10.7M | 0.03% |
+1,591,900
| New | +$10.8M |
|
|
FL
698
DELISTED
Foot Locker
FL
| $10.7M | 0.03% |
+304,600
| New | +$10.5M |
|
699
Unilever
UL
$132B
| $10.7M | 0.03% |
+234,524
| New | +$11.1M |
|
700
Morningstar
MORN
$6.94B
| $10.6M | 0.03% |
+137,000
| New | +$9.49M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.